SPAC Overview
Timeline Progress
About
Biotech Group Acquisition Corp is a blank-check company formed to complete an initial business combination. It intends to focus on biotechnology companies in North America and the Asia-Pacific region, excluding China, Hong Kong and Macau.
Investment Focus
Biopharmaceuticals
Geographic Focus
North America, Asia-Pacific region
The terms and the filing trail behind Biotech Group Acquisition Corp
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Underwriters
Extended Team Information
Led by CEO Yiru (Melody) Shi, an accounting and finance professional with public-company and biotechnology-sector experience, and CFO Manu Ohri, an experienced finance executive. Director nominees John Brugmann and Yi Wung bring financial-industry, investment, and public-company experience.